New study shows causes of previously unexplained cancers

An “unprecedented” study has revealed the most comprehensive map of cancer genomes to date. This has enables scientists to discover the genetic causes of some previously unexplained cancers. The research was carried out by an international team involving more than 1,300 scientists and clinicians from 37 countries, who analysed more than 2,600 genomes of 38 […]

read more

Mucinous tubular and spindle cell carcinoma

A recent study, published in Clinical Genitourinary Cancer, looked at the clinical features, treatment outcomes and genetic profiles of patients with mucinous tubular and spindle-cell carcinoma (MTSCC), a rare type of kidney cancer. There were 25 patients in the study, most of which had asymptomatic low-grade and localised tumours. Six patients had metastatic disease. The […]

read more

Biomarkers for kidney cancer

This interview from Practice Update with Dr Neeraj Agarwal from the Hunstman Cancer Center, Salt Lake City, Utah, USA discusses current and potential biomarkers for renal cell carcinoma (RCC). The two most common models currently used in the clinic are the Memorial Sloan-Kettering (MSKCC) model and the International Metastatic Renal Cell Carcinoma Consortium (IMDC) model, […]

read more

Personalised therapy for papillary renal cell carcinoma (pRCC)

A recent paper published in European Urology has characterised the genomic profile of papillary renal cell carcinoma (pRCC), and could help to inform future personalised therapy options for patients with this rare subtype of kidney cancer. Nature have published a review of this work. Read more here  

read more
Showing all 4 results